Unlike traditional nasal delivery systems, such as pumps, that predominantly deliver medicine to the lower nasal space and suffer from high variability and low overall absorption, our therapies are designed to achieve rapid absorption with consistent and predictable doses. The upper nasal space is believed to be a gateway for improved absorption and hence, the potential for enhanced clinical outcomes and on-demand access for molecules previously limited to injection and hospital-based use.